AH50.DE
Xtrackers Harvest CSI A500 UCITS ETF
XETRAEURETF / FUND
DELAYED
Last price
29.24
▼ 0.56 (1.88%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
29.80
Day high
29.28
Day low
29.08
Volume
255
Market cap
—
P/E (TTM)
—
52W range
26.19 – 33.70
Trailing performance
Returnvs SPY
1W
-2.18%
-1.0%
1M
-2.65%
-6.0%
3M
-6.38%
-8.8%
6M
+0.37%
-11.5%
YTD
+6.05%
-5.9%
1Y
+13.76%
-6.4%
3Y
+29.48%
-45.5%
5Y
+0.30%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Top holdings
| Symbol | Name | Weight | |
|---|---|---|---|
| 300750.SZ | Contemporary Amperex Technology Co Ltd Class A | 3.55% | |
| 300308.SZ | Zhongji Innolight Co Ltd Class A | 3.41% | |
| 600519.SS | Kweichow Moutai Co Ltd Class A | 2.87% | |
| 601318.SS | Ping An Insurance (Group) Co. of China Ltd Class A | 1.96% | |
| 300502.SZ | Eoptolink Technology Inc Ltd Class A | 1.86% | |
| 601899.SS | Zijin Mining Group Co Ltd Class A | 1.82% | |
| 600036.SS | China Merchants Bank Co Ltd Class A | 1.65% | |
| 000333.SZ | Midea Group Co Ltd Class A | 1.44% | |
| 600900.SS | China Yangtze Power Co Ltd Class A | 1.20% | |
| 688256.SS | Cambricon Technologies Corp Ltd Class A | 1.15% |
Sector exposure
Technology
29.91%
Industrials
18.82%
Basic materials
12.93%
Financial services
11.92%
Consumer cyclical
7.48%
Healthcare
6.49%
Consumer defensive
5.21%
Utilities
2.53%
Energy
2.44%
Communication services
1.68%
Real estate
0.61%
Fund profile
Fund familyDWS Investment S.A. (ETF)
Category—
Legal typeExchange Traded Fund
Expense ratio0.65%
Turnover0.0%
Total net assets$29.48M
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AH50.DE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
30.40
-3.82% from price
SMA 20
30.21
-1.37% from price
SMA 50
31.17
-4.38% from price
SMA 100
30.94
-5.50% from price
SMA 200
29.79
+0.05% from price
EMA 12
30.24
-3.32% from price
EMA 26
30.47
-4.03% from price
EMA 50
30.72
-4.81% from price
RSI (14)
43.0
Neutral
MACD (12,26,9)
-0.22
Hist -0.02
ATR (14)
0.47
1.57% of price
Realised vol 30D
26.3%
Annualised
Bollinger upper
31.22
20, 2σ
Bollinger lower
29.21
20, 2σ
50 / 200 cross
Golden
31.17 vs 29.79
Trend bias
Above 200
+0.05%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.18
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
26.3%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-12.5%
Peak to trough
Max drawdown 5Y
-40.6%
Peak to trough
ATR 14
0.47
1.57% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Net Asset Value(s)
Business Wire · 6m ago
AstraZeneca prices €2.55bn euro bond sale across four tranches
Proactive · 7m ago
Trees 'giving up': climate change hammers historic English gardens
AFP · 10m ago
Implantica to host Capital Markets Day in Stockholm on September 9
PR Newswire · 10m ago
Saudi Arabia to fund three new theme parks near Paris
Euronews · 11m ago
Cadeler: Q2 Earnings Snapshot
Associated Press · 12m ago
Solvonis raises £1.3m to fund three clinical programmes
Proactive · 12m ago
ZINZINO AB (PUBL.): INTERIM REPORT Q2 2026
PR Newswire · 13m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.